Vertex Pharmaceuticals Incorporated (VRTX -Analyst Report) was a big mover last session, as its shares rose almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading over the volatile price range of $90.22 to $97.35 in the past one-month time frame.

In the last 30 days, the company witnessed a negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher lasts.

Vertex Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD -Analyst Report), Cambrex Corporation. (CBM - Snapshot Report) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
    
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Get the full on CBPO - FREE

Get the full Snapshot Report on CBM - FREE

Get the full Analyst Report on GILD - FREE

Get the full Analyst Report on VRTX - FREE